CervoMed
CRVO
49 hedge funds and large institutions have $3.46M invested in CervoMed in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 16 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
2% less funds holding
Funds holding: 50 → 49 (-1)
24.48% less ownership
Funds ownership: 42.49% → 18.01% (-24%)
93% less capital invested
Capital invested by funds: $51.2M → $3.46M (-$47.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$728K |
| 2 |
PWM
Perigon Wealth Management
San Francisco,
California
|
+$610K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$397K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$272K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$215K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$11.9M |
| 2 |
AIC
AWM Investment Company
New York
|
-$6.56M |
| 3 |
AC
Armistice Capital
New York
|
-$5.87M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.95M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.85M |
CRVO Hedge Fund Activity: Q4 2024 in Review
49 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2024, worth a combined $3.46M — down 93% from $51.2M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of CRVO and 15 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 13 added.
The largest buyer was Woodline Partners, opening a new position worth an estimated $728K. The largest seller was RA Capital Management, exiting entirely with an estimated $11.9M sold.
- 49 institutional investors held CervoMed (CRVO) as of Q4 2024, down from 50 in Q3 2024.
- Funds reported $3.46M of CervoMed stock for Q4 2024, down 93% quarter-over-quarter.
- 15 funds opened new CervoMed positions in Q4 2024 and 16 closed out, a net change of -1 holder.
- The largest CervoMed buyer in Q4 2024 was Woodline Partners, an estimated $728K added.
- The largest CervoMed seller in Q4 2024 was RA Capital Management, an estimated $11.9M sold.
Based on aggregated 13F filings for Q4 2024.